High-intensity exercise
|
---|
|
Women with FM, n = 22
|
Healthy reference group, n = 27
|
Between-group differences
|
---|
|
0 min
|
15 min–0 min
|
0 min
|
15 min–0 min
|
0 min
|
Change 0–15 min
|
---|
|
Mean ± sd
|
∆ mean ± sd
|
p-value
|
Mean ± sd
|
∆ mean ± sd
|
p-value
|
p-value
|
p-value
|
---|
S-IGF-1 (ng/ml)
|
195 ± 60
|
11 ± 15
|
<0.001
|
181 ± 66
|
19 ± 22
|
<0.001
|
0.244
|
0.560
|
Free IGF-1 (ng/ml)
|
4.7 ± 2.6
|
−0.42 ± 0.48
|
0.014
|
4.7 ± 3.2
|
−0.56 ± 0.76
|
<0.001
|
0.755
|
0.843
|
S-IGFBP3 (ng/ml)
|
556 ± 75
|
25 ± 37
|
0.009
|
614 ± 91
|
25 ± 41
|
0.008
|
0.037
|
0.942
|
sCRP μg/ml)
|
2.1 ± 2.4
|
0.06 ± 0.16
|
0.002
|
0.70 ± 0.77
|
0.04 ± 0.06
|
<0.001
|
0.001
|
0.119
|
IL-8 (pg/ml)
|
7.5 ± 3.0
|
0.7 ± 2.9
|
0.545
|
9.7 ± 4.2
|
−0.2 ± 1.9
|
0.673
|
0.107
|
0.565
|
Pain (0–100, mm)
|
46 ± 24.4
|
−4.0 ± 16.1
|
0.291
|
2.4 ± 7.4
|
0 ± 3.6
|
0.878
|
<0.001
|
0.139
|
Fatigue in legs (0–100 mm)
|
31 ± 21
|
28 ± 20
|
<0.001
|
1.2 ± 3.1
|
12 ± 13
|
<0.001
|
<0.001
|
0.003
|
Fatigue global (0–100 mm)
|
50 ± 24
|
8.4 ± 19
|
0.007
|
3.0 ± 5.3
|
6.3 ± 10
|
<0.001
|
<0.001
|
0.414
|
-
S-IGF-1 serum insulin-like growth factor-1, S-IGFBP3 Insulin-like growth factor binding protein-3, sCRP human high sensitivity C-reactive protein, IL-8 interleukin-8